BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

AeroGen, Inc. (AEGN) Gain Approval for Entry into Chinese Market


2/17/2012 7:05:23 AM

GALWAY, Ireland--(BUSINESS WIRE)--Aerogen,(www.aerogen.com) the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China. The Aeroneb Pro is a patented vibrating mesh nebuliser which creates a fine particle aerosol for targeted drug delivery to the lungs. This unique, easy to use, multi-patient nebuliser is aimed predominately at the critical care market for treatment of a broad spectrum of patient respiratory conditions. Aerogen has also received approval for its home care device, the Aeroneb Go. Based on the same vibrating mesh technology, the Aeroneb Go brings hospital grade efficiency to inhaled drug treatment in the home.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->